Online citations, reference lists, and bibliographies.
← Back to Search

Nanotechnology For The Biologist

S. Mcneil
Published 2005 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
Nanotechnology refers to research and technology development at the atomic, molecular, and macromolecular scale, leading to the controlled manipulation and study of structures and devices with length scales in the 1‐ to 100‐nanometers range. Objects at this scale, such as “nanoparticles,” take on novel properties and functions that differ markedly from those seen in the bulk scale. The small size, surface tailorability, improved solubility, and multifunctionality of nanoparticles open many new research avenues for biologists. The novel properties of nanomaterials offer the ability to interact with complex biological functions in new ways—operating at the very scale of biomolecules. This rapidly growing field allows cross‐disciplinary researchers the opportunity to design and develop multifunctional nanoparticles that can target, diagnose, and treat diseases such as cancer. This article presents an overview of nanotechnology for the biologist and discusses “nanotech” strategies and constructs that have already demonstrated in vitro and in vivo efficacy.
This paper references
10.1097/01.rli.0000084887.47427.75
Characteristics of a New MRI Contrast Agent Prepared From Polypropyleneimine Dendrimers, Generation 2
S. Wang (2003)
10.1016/S0169-409X(99)00057-5
Monitoring pharmacokinetics of anticancer drugs: non-invasive investigation using magnetic resonance spectroscopy.
J. Griffiths (2000)
10.1002/ijc.20048
Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles
S. C. Steiniger (2004)
10.1021/AC0262210
A whole blood immunoassay using gold nanoshells.
L. R. Hirsch (2003)
10.1182/BLOOD.V41.4.529.529
The role of the sinus wall in the passage of erythrocytes through the spleen.
L. Chen (1973)
10.1080/01926230490426516
Toxicoproteomics: Serum Proteomic Pattern Diagnostics for Early Detection of Drug Induced Cardiac Toxicities and Cardioprotection
E. Petricoin (2004)
10.1158/1078-0432.CCR-03-0376
Improved Outcome When B-Cell Lymphoma Is Treated with Combinations of Immunoliposomal Anticancer Drugs Targeted to Both the CD19 and CD20 Epitopes
P. Sapra (2004)
10.1073/PNAS.0406159101
Electrical detection of single viruses.
Fernando Patolsky (2004)
Long-circulating and target-specific nanoparticles: theory to practice.
S. Moghimi (2001)
10.1007/0-306-47932-X_2
Factors and mechanism of "EPR" effect and the enhanced antitumor effects of macromolecular drugs including SMANCS.
J. Fang (2003)
10.1023/B:PHAM.0000019302.26097.cc
3H Dendrimer Nanoparticle Organ/Tumor Distribution
Shraddha S. Nigavekar (2004)
10.1016/J.IJROBP.2003.10.057
A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles.
L. Li (2004)
10.1016/S0303-2647(02)00010-2
From molecular biology to nanotechnology and nanomedicine.
K. Bogunia-Kubik (2002)
10.1016/J.IJPHARM.2004.12.022
Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study.
P. Gupta (2005)
10.1016/S0163-7827(03)00033-X
Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties.
S. Moghimi (2003)
Magnetic nanoparticles for selective therapy
P N Prasad (2003)
Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours.
A. Gabizon (1997)
10.1073/PNAS.0406835101
Adhesion at calcium oxalate crystal surfaces and the effect of urinary constituents.
Xiaoxia Sheng (2005)
10.1021/JA0296935
Multifunctional gold nanoparticle-peptide complexes for nuclear targeting.
A. Tkachenko (2003)
10.1021/BC025560X
Engineering tumor-targeted gadolinium hexanedione nanoparticles for potential application in neutron capture therapy.
M. Oyewumi (2002)
10.1080/00018739600101467
Biological atomic force microscopy: what is achieved and what is needed
Z. Shao (1996)
10.1016/S0734-9750(02)00026-5
Emerging biological materials through molecular self-assembly.
S. Zhang (2002)
10.1039/B210621N
Programmable modification of cell adhesion and zeta potential in silica microchips.
B. Kirby (2003)
10.1007/S00216-004-2526-0
Micro- and nanofluidics for DNA analysis
J. Tegenfeldt (2004)
10.1155/2002/251264
Endoscopic Microscopy
K. Sokolov (2002)
10.1126/SCIENCE.8502990
Field-flow fractionation: analysis of macromolecular, colloidal, and particulate materials.
J. Giddings (1993)
10.1016/S0959-440X(97)80037-1
High resolution imaging of native biological sample surfaces using scanning probe microscopy.
A. Engel (1997)
10.1177/153303460300200602
Optical Systems for in Vivo Molecular Imaging of Cancer
K. Sokolov (2003)
10.1038/nrd1033
Effect of pegylation on pharmaceuticals
J. Harris (2003)
10.1016/S1367-5931(02)00400-3
Biological applications of dendrimers.
M. Cloninger (2002)
10.2174/1389201043376544
Novel paramagnetic contrast agents for molecular imaging and targeted drug delivery.
G. Lanza (2004)
10.1073/pnas.2232479100
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
L. R. Hirsch (2003)
10.1016/S1359-6446(03)02903-9
Nanotech approaches to drug delivery and imaging.
S. Sahoo (2003)
10.1016/S1076-6332(03)80220-9
Molecular imaging and targeted drug delivery with a novel, ligand-directed paramagnetic nanoparticle technology.
G. Lanza (2002)
10.1016/j.mibio.2003.10.001
NanoSystems biology.
J. Heath (2003)
10.1016/S1359-6446(03)02649-7
Pharmaceutical profiling in drug discovery.
E. Kerns (2003)
10.1016/S0958-1669(02)00282-3
Luminescent quantum dots for multiplexed biological detection and imaging.
W. Chan (2002)
10.1016/J.JCONREL.2003.08.006
Brain uptake of thiamine-coated nanoparticles.
P. Lockman (2003)
10.1016/J.JCONREL.2004.09.015
Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide.
Th F Vandamme (2005)
AmBisome targeting to fungal infections.
J. Adler-Moore (1994)
10.1007/3-540-26809-X_8
Magnetic resonance signal amplification probes.
A. Bogdanov (2005)
10.1016/S1367-5931(02)00347-2
Dendritic polymer macromolecular carriers for drug delivery.
A. Patri (2002)
10.1023/B:JMSM.0000021126.32934.20
Surface modified superparamagnetic nanoparticles for drug delivery: Interaction studies with human fibroblasts in culture
A. Gupta (2004)
10.1093/JNCI/DJH124
Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent.
Hisataka Kobayashi (2004)
10.1097/00007611-195903000-00033
Bailey's Textbook of Histology
F. R. Bailey (1943)
10.1016/S0927-7765(99)00156-3
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.
Gref (2000)
10.1166/JNN.2003.077
Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.
J. Kreuter (2004)
10.1016/J.AB.2004.08.005
Ultrasensitive detection of biomolecules with fluorescent dye-doped nanoparticles.
Wei Lian (2004)
10.1080/10611860400015936
Nanoparticle Surface Charges Alter Blood–Brain Barrier Integrity and Permeability
P. Lockman (2004)
10.1162/15353500200303142
Current Advances in Molecular Imaging: Noninvasive in Vivo Bioluminescent and Fluorescent Optical Imaging in Cancer Research
G. Choy (2003)
10.1021/BI962148U
Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
D. Kirpotin (1997)
10.1126/SCIENCE.8153628
Adhesion forces between individual ligand-receptor pairs.
E. Florin (1994)
10.1517/14712598.4.8.1213
Nanoparticle-mediated gene delivery: state of the art
M. Ravi Kumar (2004)
10.1023/A:1020906307053
DC Magnetic Field Induced Magnetocytolysis of Cancer Cells Targeted by LH-RH Magnetic Nanoparticles in vitro
E. Bergey (2002)
In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors.
M. Kircher (2003)
10.1016/J.ACRA.2004.04.018
Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery.
H. Choi (2004)
Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier.
L. Fenart (1999)
10.1056/NEJMOA022749
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.
M. Harisinghani (2003)
10.1016/s0169-409x(96)00423-1
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
C. Lipinski (2001)
10.1016/J.JCONREL.2004.12.008
Developments in the rat adjuvant arthritis model and its use in therapeutic evaluation of novel non-invasive treatment by SOD in Transfersomes.
S. Simões (2005)
10.1021/BC034164R
Nanogels for oligonucleotide delivery to the brain.
S. Vinogradov (2004)
10.1016/S0076-6879(05)91012-4
Liposome-mediated suicide gene therapy in humans.
R. Reszka (2005)
10.1002/HEP.1840210130
Structure and dynamics of the fenestrae‐associated cytoskeleton of rat liver sinusoidal endothelial cells
F. Braet (1995)
10.1016/S0169-409X(02)00044-3
Nanoparticles in cancer therapy and diagnosis.
I. Brigger (2002)
10.2174/1389450043345407
Drug delivery systems: past, present, and future.
R. Mainardes (2004)
10.1038/nm1096
Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy
E. B. Voura (2004)
10.1021/BC0499127
Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy.
A. Patri (2004)
10.1023/A:1020398624602
Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells Through the Folate Receptor
A. Quintana (2004)
Magnetic nanoparticles for selective therapy, Albany, NY, The Research Foundation of The State University of New York
P. N. Prasad (2003)
10.1016/S0168-3659(99)00246-1
Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.
N. Malik (2000)
10.1016/S0079-6107(01)00011-6
Structural and functional imaging with carbon nanotube AFM probes.
J. Hafner (2001)
10.1021/BI036231A
Real-time probing of membrane transport in living microbial cells using single nanoparticle optics and living cell imaging.
X. N. Xu (2004)
10.1073/pnas.0837064100
Noncovalent functionalization of carbon nanotubes for highly specific electronic biosensors
R. J. Chen (2003)
10.1161/01.CIR.0000059651.17045.77
Nanotechnology for molecular imaging and targeted therapy.
S. Wickline (2003)
Uptake of dextrancoated monocrystalline iron oxides in tumor cells and macrophages
A. Moore (1997)
10.1016/s0076-6879(05)91007-0
Liposomal cytokines in the treatment of infectious diseases and cancer.
T. L. T. ten Hagen (2005)
10.1023/B:BMMD.0000042053.51016.B4
Opportunities for Nanotechnology-Based Innovation in Tissue Proteomics
David H. Geho (2004)
10.1177/153303460400300104
Nanoshell-Enabled Photonics-Based Imaging and Therapy of Cancer
C. Loo (2004)
Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors.
R. Campbell (2002)
10.1021/JA048792A
A quantum dot conjugated sugar ball and its cellular uptake. On the size effects of endocytosis in the subviral region.
Fumio Osaki (2004)
10.1016/S0169-409X(99)00052-6
Introduction and overview of noninvasive drug monitoring.
W. Wolf (2000)
10.1080/10611860410001728040
Liposomes Modified with Cyclic RGD Peptide for Tumor Targeting
P. Dubey (2004)
Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules.
H. Dvorak (1988)
10.1016/S0091-679X(04)75007-4
Labeling cellular targets with semiconductor quantum dot conjugates.
X. Wu (2004)
10.1016/S0092-8674(00)81683-9
The Hallmarks of Cancer
D. Hanahan (2000)
10.1021/JA0343095
Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy.
I. Roy (2003)
10.1021/JA0452471
Near-IR luminescence of monolayer-protected metal clusters.
Gangli Wang (2005)
10.1002/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO;2-P
Design of folic acid-conjugated nanoparticles for drug targeting.
B. Stella (2000)
10.1615/CRITREVTHERDRUGCARRIERSYST.V18.I6.30
Capture of stealth nanoparticles by the body's defences.
S. Moghimi (2001)
Guidance for Industry and FDA, Current Good Manufacturing Practice for Combination Products
(2004)
10.1126/SCIENCE.168.3931.527
Gel permeation chromatography.
D. D. Bly (1970)
10.1016/J.CANLET.2004.02.004
Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles.
D. O'Neal (2004)
10.1038/nrd1494
Nanosuspensions in drug delivery
Barrett E. Rabinow (2004)
10.1016/S0065-2571(00)00013-3
The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.
H. Maeda (2001)
10.1021/LA00009A040
Imaging Globular and Filamentous Proteins in Physiological Buffer Solutions with Tapping Mode Atomic Force Microscopy
M. Fritz (1995)
A model for prediction of chemotherapy response to 5-fluorouracil based on the differential distribution of 5-[18F]fluorouracil in sensitive versus resistant lymphocytic leukemia in mice.
J. Shani (1977)
10.1002/mrm.20282
MRI of transplanted pancreatic islets
D. Jirák (2004)
10.1126/SCIENCE.1062711
Nanowire Nanosensors for Highly Sensitive and Selective Detection of Biological and Chemical Species
Yunlong Cui (2001)
10.1023/A:1011485622697
The Synthesis and Testing of Anti-Cancer Therapeutic Nanodevices
J. Baker (2001)
10.1073/pnas.152463399
Nanocrystal targeting in vivo
M. Akerman (2002)
Comparative scanning, transmission and atomic force microscopy of the microtubular cytoskeleton in fenestrated liver endothelial cells.
F. Braet (1996)
10.1289/ehp.7021
Manufactured Nanomaterials (Fullerenes, C60) Induce Oxidative Stress in the Brain of Juvenile Largemouth Bass
E. Oberdörster (2004)
Guidance for Industry
(1987)
10.1016/J.JBIOTEC.2004.06.007
Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles.
R. H. Muller (2004)
10.1016/J.JCONREL.2004.03.027
SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours.
K. Greish (2004)
10.1093/NAR/GNH140
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle.
R. Schiffelers (2004)
10.1038/nature03046
Electrical generation and absorption of phonons in carbon nanotubes
B. LeRoy (2004)
10.1016/J.APRADISO.2004.05.071
Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.
Weilian Yang (2004)
Electrical generation and absorption of phonons in carbon nanotubes
M. Baudrier-Raybaut
Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells
O. C. Farokhzad (2004)
Nanosuspensions in drug
B. E. Rabinow (2004)
10.1002/mrm.20010
Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI
A. Morawski (2004)
10.1021/LA047913H
Electrochemically programmed, spatially selective biofunctionalization of silicon wires.
Yuri L Bunimovich (2004)
10.1126/SCIENCE.281.5385.2016
Quantum dot bioconjugates for ultrasensitive nonisotopic detection.
W. C. Chan (1998)
10.1038/nbt764
Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots
X. Wu (2003)
10.1002/JMRI.1880070629
Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages
A. Moore (1997)
10.1016/S0378-5173(98)00394-9
Vitamin B12-mediated transport of nanoparticles across Caco-2 cells.
G. J. Russell-Jones (1999)
10.1093/TOXSCI/KFG228
Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats.
D. Warheit (2004)
10.1385/1-59259-429-8:107
Nonviral liposomes.
A. Miller (2004)
10.1002/JPS.1063
Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes.
R. Campbell (2001)
10.1002/SCA.4950260409
Atomic force microscopy imaging of retroviruses: human immunodeficiency virus and murine leukemia virus.
Y. Kuznetsov (2004)
10.1146/ANNUREV.BIOENG.5.011303.120723
Engineered nanomaterials for biophotonics applications: improving sensing, imaging, and therapeutics.
J. West (2003)
10.1038/nbt994
In vivo cancer targeting and imaging with semiconductor quantum dots
X. Gao (2004)
10.1162/153535003322750646
Current advances in molecular imaging: noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research.
G. Choy (2003)
10.2174/1567204043396604
Physicochemical profiling (solubility, permeability and charge state).
A. Avdeef (2001)
Nanotoxicology. Nanotechnology grows up
R. F. Service (2004)
SMAdoxorubicin, a new polymeric micellar drug for effective targeting to solid tumors
K. Greish (2004)



This paper is referenced by
10.1016/J.APRADISO.2007.08.017
Determination of biological vector characteristics and nanoparticle dimensions for radioimmunotherapy with radioactive nanoparticles.
V. Nuttens (2008)
10.1039/B902394A
Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications
R. Qiao (2009)
Nanoparticles for simultaneous near-infrared and magnetic biomolecular imaging
A. Servati (2012)
10.1364/OE.19.017563
Imaging the uptake of gold nanoshells in live cells using plasmon resonance enhanced four wave mixing microscopy.
N. Garrett (2011)
10.4161/cbt.4.2.1577
Nanotechnology in Cancer Diagnosis and Treatment
Somaia (2015)
Novel Immunogens Of Cellular Immunity Revealed Using In Vitro Human Cell-based Approach
Brian C. Schanen (2012)
10.1007/978-3-319-95807-1_7
Nano/Microparticles for Retina and Posterior Diseases
A. Patel (2018)
10.1007/978-1-60327-569-9_9
Electrochemical detection of DNA hybridization using micro and nanoparticles.
M. Castañeda (2009)
10.1063/1.4795531
Effect of ZnO nanoparticles on nasopharyngeal cancer cells viability and respiration
R. Prasanth (2013)
10.1063/1.3455338
Positioning and stretching of actin filaments by electric fields
Christoph Wigge (2010)
10.3920/WMJ2011.1318
Biosensors and Nanomaterials and their Application for Mycotoxin Determination
I. Tothill (2011)
10.1002/9783527610419.NTLS0107
Nanotechnologies for Diagnosis – Present and Future
G. Hughes (2007)
10.1002/9781118873151.CH10
Photoacoustic and Ultrasound Imaging with Nanosized Contrast Agents
Mansik Jeon (2015)
10.4155/tde-2019-0077
Recent advancements in brain tumor targeting using magnetic nanoparticles.
Himanshu Gandhi (2020)
10.1007/978-3-030-44921-6_7
Nanopharmaceuticals: Healthcare Applications and Safety Evaluations
O. S. Adeyemi (2021)
ROLE OF NANOTECHNOLOGY IN ORAL CANCER DIAGNOSIS AND THERAPEUTICS
S. Sharma (2019)
Cancer Nanotechnology: Hopes and Hurdles
Syed Abdul Kuddus (2017)
10.2174/9781608058846114030010
Theranostic Metallic Nanomedicine in Oncology: New Insights and Concerns
S. Akhter (2014)
10.1049/iet-nbt.2009.0014
Hepatocyte growth factor incorporated chitosan nanoparticles differentiate murine bone marrow mesenchymal stem cell into hepatocytes in vitro.
S. Pulavendran (2010)
10.1007/s10753-012-9437-6
Anti-inflammation Effects of Sophora flavescens Nanoparticles
Chun-Chao Han (2012)
10.1155/2013/794582
Synthesis of Alginate-Curcumin Nanocomposite and Its Protective Role in Transgenic Drosophila Model of Parkinson's Disease
Y. Siddique (2013)
10.17169/REFUBIUM-7766
A thermo-responsive drug release system for combined chemohyperthermia
Fusheng Yan (2015)
10.13005/BBRA
Emerging Trends of Nanotechnology and Nanoscience in Food Safety
N. Sree (2010)
The actinin family of actin crosslinking proteins: natural functions and potential applications in synthetic biology
Anita Catherine Honor Murphy (2016)
10.3390/ijerph17031005
Exposure of CuO Nanoparticles Contributes to Cellular Apoptosis, Redox Stress, and Alzheimer’s Aβ Amyloidosis
Y. Shi (2020)
10.1016/B978-0-12-803581-8.00581-6
Inorganic Core–Shell Nanoparticles
S. Kudera (2014)
10.22159/IJAP.2018V10I5.29569
ENRICHMENT OF IN VIVO EFFICACY OF CATECHIN RICH EXTRACT WITH THE APPLICATION OF NANOTECHNOLOGY
P. Monika (2018)
Application of Nanotechnology in the Agro-Food Sector
C. Lopes (2013)
10.1002/9783527670383.CH14
Life and death of Trypanosoma brucei: new perspectives for drug development.
T. Barth (2013)
10.1111/j.1748-720X.2012.00706.x
What is Unique about Nanomedicine? The Significance of the Mesoscale
G. Khushf (2012)
Electrochemical stripping analysis and nanoparticles for affinity biosensors
C. Briones (2008)
10.1186/1743-8977-7-40
Management of nanomaterials safety in research environment
A. Groso (2010)
See more
Semantic Scholar Logo Some data provided by SemanticScholar